Artivion | CRY - Umsatzerlöse

Aktienkurs
35.29
Täglich Wechseln
-1.10 -3.02%
Monatlich
-8.46%
Jährlich
45.53%
Q1 Prognose
35.04




Der Umsatz Veränderung Datum
Abbott USD 11.46B 90M 2025-12
Accuray USD 116.17M 14.63M 2024-12
AngioDynamics USD 79.43M 3.72M 2025-09
Artivion USD 115.99M 2.6M 2025-12
AtriCure USD 140.5M 6.2M 2025-12
Baxter International USD 2.97B 130M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Boston Scientific USD 5.29B 220M 2025-12
Edwards Lifesciences USD 1.57B 20M 2025-12
Inogen USD 74.93M 504K 2024-09
Integra LifeSciences USD 434.9M 32.84M 2025-12
J&J USD 24.6B 610M 2025-12
Mesa Laboratories USD 62.84M 5.01M 2024-12
Orthofix International USD 219.91M 14.28M 2025-12
Pfizer USD 17.58B 880M 2025-12
ResMed USD 1.4B 100M 2025-12
Stryker USD 7.2B 1.14B 2025-12
Surmodics USD 29.92M 96.16M 2024-12
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teleflex USD 568.98M 344.02M 2025-12
Terumo JPY 296.63B 21.66B 2025-12
Trinity Biotech USD 14.31M 1.55M 2025-09